HKD 1.26
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 101.75 Million CNY | 41.83% |
2022 | 61.95 Million CNY | -0.54% |
2021 | 62.28 Million CNY | 12.17% |
2020 | 55.53 Million CNY | -27.9% |
2019 | 77.02 Million CNY | 24.34% |
2018 | 61.94 Million CNY | 15.12% |
2017 | 53.8 Million CNY | 19.32% |
2016 | 45.09 Million CNY | 29.51% |
2015 | 34.81 Million CNY | 5.0% |
2014 | 33.16 Million CNY | 80.4% |
2013 | 18.38 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 26.03 Million CNY | -49.62% |
2023 Q2 | 27.57 Million CNY | -21.79% |
2023 FY | - CNY | 41.83% |
2023 Q4 | 51.67 Million CNY | 87.43% |
2022 Q4 | 35.25 Million CNY | 40.27% |
2022 FY | - CNY | -0.54% |
2022 Q2 | 25.13 Million CNY | -39.95% |
2021 Q2 | 20.43 Million CNY | -42.87% |
2021 FY | - CNY | 12.17% |
2021 Q4 | 41.85 Million CNY | 104.81% |
2020 Q4 | 35.77 Million CNY | 81.02% |
2020 FY | - CNY | -27.9% |
2020 Q2 | 19.76 Million CNY | -60.06% |
2019 FY | - CNY | 24.34% |
2019 Q4 | 49.47 Million CNY | 79.58% |
2019 Q2 | 27.54 Million CNY | -40.67% |
2018 FY | - CNY | 15.12% |
2018 Q2 | 15.51 Million CNY | 0.0% |
2018 Q4 | 46.43 Million CNY | 199.36% |
2017 Q2 | 26.18 Million CNY | -1.65% |
2017 FY | - CNY | 19.32% |
2016 FY | - CNY | 29.51% |
2016 Q4 | 26.62 Million CNY | 33.77% |
2016 Q2 | 19.9 Million CNY | 4.33% |
2015 FY | - CNY | 5.0% |
2015 Q4 | 19.07 Million CNY | 21.16% |
2015 Q2 | 15.74 Million CNY | 0.0% |
2014 FY | - CNY | 80.4% |
2013 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -344.099% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 67.977% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -4914.884% |
Prosperous Future Holdings Limited | -19.68 Million HKD | 616.875% |
Huasheng International Holding Limited | 19.67 Million HKD | -417.085% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | -65.383% |
Evergreen Products Group Limited | 140.78 Million HKD | 27.724% |
EC Healthcare | 737.83 Million HKD | 86.209% |
Ming Fai International Holdings Limited | 211.83 Million HKD | 51.966% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | 84.498% |
SuperRobotics Holdings Limited | -7.39 Million HKD | 1475.213% |
Takbo Group Holdings Limited | 25.8 Million HKD | -294.326% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | 34.007% |